Capital World Investors holds 0.2% of Zai Lab
Capital World Investors, a division of Capital Research and Management Company and its affiliates, reports beneficial ownership of 1,723,600 shares of Zai Lab Ltd. common stock.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Capital World Investors, a division of Capital Research and Management Company and its affiliates, reports beneficial ownership of 1,723,600 shares of Zai Lab Ltd. common stock. This represents 0.2% of the 1,119,628,030 shares it believes are outstanding.
The firm has sole voting and dispositive power over these shares and no shared power. It states the position is held in the ordinary course of business and not for the purpose of changing or influencing control of Zai Lab, and that it owns less than five percent of the class.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What percentage of Zai Lab (ZLAB) does Capital World Investors report owning?
Does Capital World Investors seek to influence control of Zai Lab (ZLAB)?
What type of filing did Capital World Investors make regarding Zai Lab (ZLAB)?
Who signed the Zai Lab (ZLAB) Schedule 13G/A for Capital World Investors?
AI-generated analysis. How Rhea-AI works. Not financial advice.